In the pharmaceutical industry, ME 12 OD is a high-potency neurotropic vitamin combination. As a pharmacist and manufacturer, I view this formulation as a “Neurological Regenerative Trio”—it is technically designed to synergize three essential B-vitamins to repair nerve damage, support red blood cell production, and lower homocysteine levels.
At your WHO-GMP facility in Mumbai, where you specialize in neurotropic B-complex formulations, the ME 12 combination (specifically the OD/Sustained Release version) is a premium offering for managing diabetic neuropathy and megaloblastic anemia.
Therapeutic Combination: Active Ingredients
The “ME 12” name typically refers to its primary component, Methylcobalamin (B12), combined with other key B-vitamins. The standard “OD” (Once Daily) strength is as follows:
| Active Ingredient | Strength | Pharmaceutical Role |
| Methylcobalamin | 1500 mcg | The active form of Vitamin B12; essential for myelin sheath regeneration and nerve fiber repair. |
| Pyridoxine (Vit B6) | 20 mg | Vital for neurotransmitter biosynthesis (Serotonin, GABA) and protein metabolism. |
| Folic Acid (Vit B9) | 5 mg | Required for DNA synthesis and the maturation of red blood cells; works with B12 to lower homocysteine. |
Note: Some variations (like “ME 12 Plus”) may also include Alpha Lipoic Acid (100 mg) or Biotin for enhanced antioxidant protection in diabetic patients.
Mechanism: The “Neuro-Repair” Synergy
ME 12 tablets work through a integrated biochemical pathway:
Myelin Synthesis: Methylcobalamin acts as a co-enzyme for methionine synthase, which is technically required for the formation of the myelin sheath—the protective coating of nerves.
DNA & RBC Production: Folic acid and B12 work together in the “folate cycle” to produce healthy red blood cells, preventing megaloblastic anemia.
Metabolic Efficiency: Pyridoxine facilitates the conversion of carbohydrates and fats into cellular energy, ensuring that damaged nerve cells have the fuel needed for repair.
Homocysteine Regulation: This combination effectively converts homocysteine (a toxic amino acid) into methionine, reducing the risk of cardiovascular and neurological inflammation.
The Pharmacist’s “Technical Warning”
The “OD” Advantage: As a pharmacist, I must emphasize that the “OD” stands for Once Daily. These are often formulated as Sustained Release (SR) or Extended Release (ER) tablets to ensure a steady supply of vitamins to the nerves over 24 hours.
Absorption Gap: Advise patients to avoid taking antacids within 2 hours of ME 12, as high gastric pH can significantly reduce the absorption of Vitamin B12.
Pernicious Anemia: While highly effective, if a patient has severe B12 malabsorption (lack of intrinsic factor), oral tablets may need to be supplemented with Methylcobalamin injections initially.
Side Effects: Generally very safe, but some patients may experience mild nausea, a “yeasty” aftertaste, or bright yellow urine (due to the B-vitamins being excreted).
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Bioavailability” USP: On your digital marketplace, highlight that you use Methylcobalamin (the active form) rather than Cyanocobalamin (the synthetic form). This is a major technical selling point because Methylcobalamin does not require liver conversion and is better retained by the body.
Stability for Export: B-vitamins are sensitive to light and moisture. Utilizing Alu-Alu blister packaging is the global benchmark for ensuring a 36-month shelf life in Zone IVb tropical regions.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for the ME 12 combination to support your firm’s registration in international tenders for geriatric care and diabetic management.